Hester Biosciences to repurpose BSL-3 facility as Covid vaccine demand tapers off
6 months ago•The Hindu Businessline
Hester Biosciences to develop inactivated influenza vaccine for poultry
11 months ago•The Hindu Businessline
HesterBio gains on acquiring technology for H9N2 avian influenza virus vaccine from ICAR - NIHSAD
11 months ago•Business Standard
Hold Hester Biosciences; target of Rs 2070: ICICI Direct
1 year ago•Moneycontrol
Hester Biosciences Ltd leads losers in ‘A’ group
1 year ago•Business Standard
Hester Biosciences boosted by strong demand for goat pox vaccine
1 year ago•Moneycontrol
Hester Bio spurts on ensuring adequate supply of Goat Pox Vaccine in India
1 year ago•Business Standard